Glaucoma treatment has changed.
New tools.
New options.
New hope.
Dr. Inder Paul Singh has seen it all.
He spoke about how glaucoma care evolved—and where it’s headed.
If you have glaucoma or treat patients, this matters to you.
Where We Started
Dr. Singh began by recalling past methods.
Most patients used drops
Surgeries were invasive and risky
Side effects made adherence tough
Back then, the goal was simple:
Lower the pressure, save the vision.
But many patients still lost sight.
What Changed?
Technology brought options.
Dr. Singh pointed to MIGS—minimally invasive glaucoma surgery.
What makes MIGS different?
Small incisions
Shorter recovery
Can be combined with cataract surgery
Fewer side effects than traditional surgery
This helped patients who couldn’t manage drops.
It also made early intervention easier.
What Did Patients Say?
Patients noticed the difference.
Dr. Singh shared a case:
A woman in her 60s struggled with daily drops.
She missed doses and her pressure spiked.
After MIGS, she needed fewer drops and her pressure stabilized.
Her stress dropped too.
Not Every Case Is the Same
Dr. Singh stressed this:
What works for one patient may not work for another.
That’s why doctors need tools.
Not just one.
But a full range.
Drops
Lasers
MIGS
Traditional surgery
And now, gene therapy
What’s New: Gene Therapy
Gene therapy isn’t routine yet.
But trials are happening.
The idea is to change how the eye regulates pressure.
One treatment. Long-lasting effect.
Possibly no need for daily medication.
It’s still early.
But it could change how you treat glaucoma.
Why Personalized Care Matters
Dr. Singh asks doctors to:
Listen more
Ask about daily routines
Check how patients manage their medication
Adjust plans as needed
For example:
A young worker with irregular shifts may forget drops.
An older patient might have arthritis and can’t squeeze a bottle.
Matching the treatment to the lifestyle is key.
Lessons from the Past
He warned against overconfidence.
Years ago, some believed drops were enough.
Then came proof:
Even with low pressure, some patients went blind.
That taught doctors to look beyond pressure.
They now monitor nerve fiber layers, visual fields, and optic nerve health.
What Can You Do?
Whether you’re a patient or a doctor:
Track your eye pressure
Ask about new options
Don’t settle for what was available 10 years ago
Read studies and updates
Bring up concerns in every checkup
Glaucoma isn’t just about numbers.
It’s about protecting your sight—your future.
Dr. Singh’s Message
He ended with this:
We’ve come far, but not far enough.
You have more tools than ever.
Use them wisely.
And keep asking:
What else can help this patient?
